Security key
29405E208
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB)
CUSIP: 29405E208
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 711,295
- Total 13F value
- $337,193
- Share change
- +226,086
- SEC-reported price per share
- $0.47
- Number of holders
- 16
- Value change
- +$106,360
- Number of buys
- 10
- Number of sells
- 6
- Shares outstanding
- 1,022,530
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
16
Top holders
10
ENVB full security history
Ownership snapshot
Full 13F holder table
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AdvisorShares Investments...
Disclosed value leader
AdvisorShares Investments...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 31%
Showing 1-6 of 15 holder rows.
Quick read
AdvisorShares Investments LLC leads the comparable SEC ownership view at 31%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AdvisorShares Investments LLC's linked filing trail.
Comparable ownership
Top 5
AdvisorShares Investments LLC
31%
GEODE CAPITAL MANAGEMENT, LLC
4.4%
UBS Group AG
4.3%
BlackRock Finance, Inc.
2.9%
VANGUARD GROUP INC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC |
13F
Company
|
31%
|
$189,911
317,047 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
4.4%
|
$27,688
44,659 shares
|
— | 30 Jun 2024 |
| UBS Group AG |
13F
Company
|
4.3%
|
$27,268
43,560 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
2.9%
|
$18,522
29,578 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.8%
|
$11,396
18,198 shares
|
— | 30 Jun 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
1.5%
|
$9,543
15,240 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
711,295
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
17
Q3 2024 holders
16
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|